Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats

Journal of Bone and Joint Surgery

Volumn 85, Issue 5, 2003, Pages 905-911

  Wang, Jeffrey C ^a   Kanim, Linda E A ^a   Yoo, Stephen ^a   Campbell, Patricia A ^a   Berk, Arnold J ^a,b   Lieberman, Jay R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2;

ANIMAL CELL; ARTHRODESIS; ARTICLE; BONE GRAFT; BONE MARROW CELL; BONE MATRIX; DEMINERALIZATION; DRUG EFFECT; GENE THERAPY; GENE TRANSFER; HETEROTOPIC OSSIFICATION; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; PSEUDARTHROSIS; RAT; SPINE FUSION; TRABECULAR BONE; VIRAL GENE THERAPY;

EID: 0038333622     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200305000-00020     Document Type: Article

References (28)

1. Boden SD, Schimandle JH, Hutton WC. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine. 1995;20:2633-44.
2. Boden SD, Schimandle JH. Biologic enhancement of spinal fusion. Spine. 1995;20(24 Suppl):113S-23S.
3. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine. 1995;20:412-20.
4. Boden SD, Schimandle JH, Hutton WC. Lumbar intertransverse-process spinal arthrodesis with use of a bovine bone-derived osteoinductive protein. A preliminary report. J Bone Joint Surg Am. 1995;77:1404-17.
5. Boden SD, Schimandle JH, Hutton WC, Chen MI. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part I: Biology of spinal fusion. Spine. 1995;20:2626-32.
6. Boden SD, Sumner DR. Biologic factors affecting spinal fusion and bone regeneration. Spine. 1995;20(24 Suppl):102S-12S.
7. Helm GA, Sheehan JM, Sheehan JP, Jane JA Jr, diPierro CG, Simmons NE, Gillies GT, Kallmes DF, Sweeney TM. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurosurg. 1997;86:93-100.
8. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am. 1999;81:905-17.
9. Lieberman JR, Le LQ, Wu L, Finerman GA, Berk A, Witte ON, Stevenson S. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res. 1998;16:330-9.
10. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR. Bone morphogenetic protein-2: biology and applications. Clin Orthop. 1996;324:39-46.
11. Schimandle JH, Boden SD. Spine update. The use of animal models to study spinal fusion. Spine. 1994;19:1998-2006.
12. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine. 1995;20:1326-37.
13. Wang JS. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand Suppl. 1996; 269:1-33.
14. Damien CJ, Grob D, Boden SD, Benedict JJ. Purified bovine BMP extract and collagen for spine arthrodesis: preclinical safety and efficacy. Spine. 2002; 27(16 Suppl 1):S50-8.
15. Iwata H, Sakano S, Itoh T, Bauer TW. Demineralized bone matrix and native bone morphogenetic protein in orthopaedic surgery. Clin Orthop. 2002;395: 99-109.
16. Berven S, Tay BK, Kleinstueck FS, Bradford DS. Clinical applications of bone graft substitutes in spine surgery: consideration of mineralized and demineralized preparations and growth factor supplementation. Eur Spine J. 2001; 10 Suppl 2:S169-77.
17. Sandhu HS, Khan SN, Suh DY, Boden SD. Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview. Eur Spine J. 2001;10 Suppl 2:S122-31.
18. Holliger EH, Trawick RH, Boden SD, Hutton WC. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: a comparison between two bone graft materials - rhBMP-2 and autograft. J Spinal Disord. 1996;9:125-8.
19. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H, Fujimura S. Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int. 1997;60:291-6.
20. Boo JS, Yamada Y, Okazaki Y, Hibino Y, Okada K, Hata K, Yoshikawa T, Sugiura Y, Ueda M. Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg. 2002;13:231-9; discussion 240-3.
21. Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun. 2002;292:144-52.
22. Lisignoli G, Fini M, Giavaresi G, Nicoli AN, Toneguzzi S, Facchini A. Osteogenesis of large segmental radius defects enhanced by basic fibroblast growth factor activated bone marrow stromal cells grown on non-woven hyaluronic acid-based polymer scaffold. Biomaterials. 2002;23:1043-51.
23. Shang Q, Wang Z, Liu W, Shl Y, Cui L, Cao Y. Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg, 2001;12:586-93.
24. Long MW. Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis. 2001;27:677-90.
25. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res. 1999;46:193-202.
26. Uludag H, Gao T, Porter TJ, Friess W, Wozney JM. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am. 2001;83 Suppl 1:S128-35.
27. Alden TD, Pittman DD, Beres EJ, Hankins GR, Kallmes DF, Wisotsky BM, Kerns KM, Helm GA. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg. 1999;90(1 Suppl):109-14.
28. Alden TD, Pittman DD, Hankins GR, Beres EJ, Engh JA, Das S, Hudson SB, Kerns KM, Kallmes DF, Helm GA. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther, 1999; 10:2245-53.